A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins

B. A. Corbett, A. B. Kantor, H. Schulman, W. L. Walker, L. Lit, Paul Ashwood, David M Rocke, Frank R Sharp

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Modern methods that use systematic, quantitative and unbiased approaches are making it possible to discover proteins altered by a disease. To identify proteins that might be differentially expressed in autism, serum proteins from blood were subjected to trypsin digestion followed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) on time-of-flight (TOF) instruments to identify differentially expressed peptides. Children with autism 4-6 years of age (n=69) were compared to typically developing children (n=35) with similar age and gender distributions. A total of 6348 peptide components were quantified. Of these, five peptide components corresponding to four known proteins had an effect size >0.99 with a P<0.05 and a Mascot identification score of 30 or greater for autism compared to controls. The four proteins were: Apolipoprotein (apo) B-100, Complement Factor H Related Protein (FHR1), Complement C1q and Fibronectin 1 (FN1). In addition, apo B-100 and apo A-IV were higher in children with high compared to low functioning autism. Apos are involved in the transport of lipids, cholesterol and vitamin E. The complement system is involved in the lysis and removal of infectious organisms in blood, and may be involved in cellular apoptosis in brain. Despite limitations of the study, including the low fold changes and variable detection rates for the peptide components, the data support possible differences of circulating proteins in autism, and should help stimulate the continued search for causes and treatments of autism by examining peripheral blood.

Original languageEnglish (US)
Pages (from-to)292-306
Number of pages15
JournalMolecular Psychiatry
Volume12
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Apolipoproteins
Autistic Disorder
Proteomics
Complement System Proteins
Serum
Apolipoprotein B-100
Peptides
Proteins
Complement C1q
Complement Factor H
Electrospray Ionization Mass Spectrometry
Age Distribution
Vitamin E
Fibronectins
Liquid Chromatography
Trypsin
Blood Proteins
Digestion
Cholesterol
Apoptosis

Keywords

  • Apolipoprotein
  • Apolipoprotein B-100
  • Autism
  • Blood
  • Complement
  • Proteomics

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health

Cite this

A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. / Corbett, B. A.; Kantor, A. B.; Schulman, H.; Walker, W. L.; Lit, L.; Ashwood, Paul; Rocke, David M; Sharp, Frank R.

In: Molecular Psychiatry, Vol. 12, No. 3, 03.2007, p. 292-306.

Research output: Contribution to journalArticle

@article{9416ee67785540b59b6370987973bff6,
title = "A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins",
abstract = "Modern methods that use systematic, quantitative and unbiased approaches are making it possible to discover proteins altered by a disease. To identify proteins that might be differentially expressed in autism, serum proteins from blood were subjected to trypsin digestion followed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) on time-of-flight (TOF) instruments to identify differentially expressed peptides. Children with autism 4-6 years of age (n=69) were compared to typically developing children (n=35) with similar age and gender distributions. A total of 6348 peptide components were quantified. Of these, five peptide components corresponding to four known proteins had an effect size >0.99 with a P<0.05 and a Mascot identification score of 30 or greater for autism compared to controls. The four proteins were: Apolipoprotein (apo) B-100, Complement Factor H Related Protein (FHR1), Complement C1q and Fibronectin 1 (FN1). In addition, apo B-100 and apo A-IV were higher in children with high compared to low functioning autism. Apos are involved in the transport of lipids, cholesterol and vitamin E. The complement system is involved in the lysis and removal of infectious organisms in blood, and may be involved in cellular apoptosis in brain. Despite limitations of the study, including the low fold changes and variable detection rates for the peptide components, the data support possible differences of circulating proteins in autism, and should help stimulate the continued search for causes and treatments of autism by examining peripheral blood.",
keywords = "Apolipoprotein, Apolipoprotein B-100, Autism, Blood, Complement, Proteomics",
author = "Corbett, {B. A.} and Kantor, {A. B.} and H. Schulman and Walker, {W. L.} and L. Lit and Paul Ashwood and Rocke, {David M} and Sharp, {Frank R}",
year = "2007",
month = "3",
doi = "10.1038/sj.mp.4001943",
language = "English (US)",
volume = "12",
pages = "292--306",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins

AU - Corbett, B. A.

AU - Kantor, A. B.

AU - Schulman, H.

AU - Walker, W. L.

AU - Lit, L.

AU - Ashwood, Paul

AU - Rocke, David M

AU - Sharp, Frank R

PY - 2007/3

Y1 - 2007/3

N2 - Modern methods that use systematic, quantitative and unbiased approaches are making it possible to discover proteins altered by a disease. To identify proteins that might be differentially expressed in autism, serum proteins from blood were subjected to trypsin digestion followed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) on time-of-flight (TOF) instruments to identify differentially expressed peptides. Children with autism 4-6 years of age (n=69) were compared to typically developing children (n=35) with similar age and gender distributions. A total of 6348 peptide components were quantified. Of these, five peptide components corresponding to four known proteins had an effect size >0.99 with a P<0.05 and a Mascot identification score of 30 or greater for autism compared to controls. The four proteins were: Apolipoprotein (apo) B-100, Complement Factor H Related Protein (FHR1), Complement C1q and Fibronectin 1 (FN1). In addition, apo B-100 and apo A-IV were higher in children with high compared to low functioning autism. Apos are involved in the transport of lipids, cholesterol and vitamin E. The complement system is involved in the lysis and removal of infectious organisms in blood, and may be involved in cellular apoptosis in brain. Despite limitations of the study, including the low fold changes and variable detection rates for the peptide components, the data support possible differences of circulating proteins in autism, and should help stimulate the continued search for causes and treatments of autism by examining peripheral blood.

AB - Modern methods that use systematic, quantitative and unbiased approaches are making it possible to discover proteins altered by a disease. To identify proteins that might be differentially expressed in autism, serum proteins from blood were subjected to trypsin digestion followed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) on time-of-flight (TOF) instruments to identify differentially expressed peptides. Children with autism 4-6 years of age (n=69) were compared to typically developing children (n=35) with similar age and gender distributions. A total of 6348 peptide components were quantified. Of these, five peptide components corresponding to four known proteins had an effect size >0.99 with a P<0.05 and a Mascot identification score of 30 or greater for autism compared to controls. The four proteins were: Apolipoprotein (apo) B-100, Complement Factor H Related Protein (FHR1), Complement C1q and Fibronectin 1 (FN1). In addition, apo B-100 and apo A-IV were higher in children with high compared to low functioning autism. Apos are involved in the transport of lipids, cholesterol and vitamin E. The complement system is involved in the lysis and removal of infectious organisms in blood, and may be involved in cellular apoptosis in brain. Despite limitations of the study, including the low fold changes and variable detection rates for the peptide components, the data support possible differences of circulating proteins in autism, and should help stimulate the continued search for causes and treatments of autism by examining peripheral blood.

KW - Apolipoprotein

KW - Apolipoprotein B-100

KW - Autism

KW - Blood

KW - Complement

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=33847292420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847292420&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4001943

DO - 10.1038/sj.mp.4001943

M3 - Article

VL - 12

SP - 292

EP - 306

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 3

ER -